Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012:7:55-64.
doi: 10.2147/CIA.S25215. Epub 2012 Feb 24.

Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence

Pierre-Olivier Lang  1 , Aline Mendes, Jennifer Socquet, Noémie Assir, Sheila Govind, Richard Aspinall
Affiliations
Review

Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence

Pierre-Olivier Lang et al. Clin Interv Aging. 2012.

Abstract

Foremost amongst the diseases preventable by vaccination is influenza. Worldwide, influenza virus infection is associated with serious adverse events leading to hospitalization, debilitating complications, and death in elderly individuals. Immunization is considered to be the cornerstone for preventing these adverse health outcomes, and vaccination programs are timed to optimize protection during the annual influenza season. Trivalent inactivated influenza virus vaccines are believed to be both effective and cost-saving; however, in spite of widespread influenza vaccination programs, rates of hospitalization for acute respiratory illness and cardiovascular diseases have been increasing in this population during recent annual influenza seasons. From meta-analyses summarizing estimates of influenza vaccine effectiveness from available observational clinical studies, this review aims to examine how effective current influenza vaccine strategies are in the aging and older adult population and to analyze which are the most important biases that interfere with measurements of influenza vaccine effectiveness. Furthermore, consideration is given to strategies that should be adopted in order to optimize influenza vaccine effectiveness in the face of immune exhaustion.

Keywords: hemagglutinin activity inhibition; hemagglutinin inhibition; immunosenescence; influenza vaccine effectiveness; influenza virus infection; innate immunity; older adults.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Development of immunosenescence with advancing age and its impact on the ability of the immune system to respond to influenza virus antigen. Potential impacts of immunotherapy of immunosenescence are also presented. Abbreviations: CMV, cytomegalovirus; IL, interleukin; TIV, trivalent inactivated influenza vaccine; TNF-α, tumor necrosis factor-alpha.
See this image and copyright information in PMC

References

    1. World Health Organization (WHO) Influenza (Seasonal) Fact sheet N°211. Apr, 2009. [Accessed November 30, 2011]. [updated 2011]. Available from: http://www.who.int/mediacentre/factsheets/fs211/en/
    1. Centers for Disease Control and Prevention (CDC) Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Wkly Rep. 2011;60(33):1128–1132. - PubMed
    1. National Advisory Committee on Immunization. Statement on seasonal influenza vaccine for 2011–2012. [Accessed October 30, 2011];Canada Communicable Disease Report (CCDR) 2011 37(ACS5):1–55. [updated 2011]. Available from: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/11vol37/acs-dcc-5/assets/p.... - PMC - PubMed
    1. Michiels B, Govearts F, Remmen R, Vermeire E, Coenen S. A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups. Vaccine. 2011;29(49):9159–9170. - PubMed
    1. European Centre for Disease Prevention Control. Seasonal human influenza and vaccination. [Accessed October 30, 2011]. [updated 2011]. Available from: http://www.ecdc.europa.eu/en/press/Press%20Releases/071012_PR_SI_Prof_Fa....

Substances